Company & Leadership
Our Mission: Devoted to developing antibody-based therapies that allow pets with chronic diseases to thrive, not just survive.
Founding of Vetigenics
Pioneers in pet and human antibody therapeutics
Vetigenics scientific founders, Nicola Mason, BVetMed, Ph.D. and Don Siegel, Ph.D., M.D. of the University of Pennsylvania are internationally recognized leaders in veterinary medicine, immunotherapy, and phage display technology. Their complementary expertise naturally resulted in an unrivaled ability to generate and validate best in class antibody-based therapeutics to treat chronic diseases in both pets and humans.
Professor of Medicine at University of Pennsylvania, Founder of Vetigenics, and a pioneer in the field of Comparative Immunotherapy
Professor of Pathology & Laboratory Medicine at University of Pennsylvania, Founder of Vetigenics, and globally recognized for groundbreaking contributions in Antibody Discovery and Cell Therapy